HEALTHWHRO HAMPTON ROADS
Virginia budget expands Medicaid access to sickle cell gene therapy
Virginia's budget has expanded Medicaid access to include sickle cell gene therapy. However, providers note that the treatment remains a long, expensive, and difficult process to access.
Mentioned
Related Signal
Adjacent reporting
- Gene therapy for children with sickle cell disease approved by FDA
- Opinion: $2 million gene therapy cures require a financing model
- Aflac general counsel: Georgia lawmakers took a crucial step forward on sickle cell disease – but there’s more work to be done
- Clinical trial shows gene editing works for β-Thalassaemia, too
- Groundbreaking research led in Nashville could change sickle cell treatment for children